Pancreatic Stone Protein Testing Market Size

  • Report ID: 4566
  • Published Date: Jul 30, 2024
  • Report Format: PDF, PPT

Pancreatic Stone Protein Testing Market Size

Pancreatic Stone Protein Market size was valued at USD 4.11 Billion in 2023 and is set to reach USD 5.89 Billion by the end of 2036, expanding at around 2.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of pancreatic stone protein testing is assessed at USD 4.21 Billion. The growth of the market can be attributed to the globally rising prevalence of chronic diseases, caused by pancreatic stone formation. Some of these diseases include acute appendicitis, diabetes, gallstones, and optic atrophy, which is expected to drive the demand for global pancreatic stone protein testing market during the forecast period. It was observed that, in American Indians, gallstones are prevalent at a rate of about 55% to 65%, while the rate in white adults in developed countries is approximately 8% to 15%. Likewise, the rate of acute pancreatitis symptoms is higher in developing countries as well as in developed countries. For instance, the annual incidence of acute pancreatic in the U.S. ranges from 20 to 50 per 100,000 population.

The global pancreatic stone protein testing market size is expected to expand during the forecast period owing to its potential for detecting life-threatening diseases and monitoring the response to treatment. Additionally, the increasing cases of chronic & hereditary pancreatitis and pancreatic cancer worldwide are estimated to propel the growth of the global pancreatic stone protein testing market over the forecast period. According to the National Center for Biotechnology Information, a pancreatic cancer diagnosis is the seventh leading cause of cancer-related death in the world. There have been 458,918 new cases of pancreatic cancer recorded globally in 2018, and there are estimated to be 355,317 new cases occurring until the year 2040. Furthermore, assay techniques such as ELISA and immunoassay devices are some of the global pancreatic stone protein testing market trends expected to fuel the market growth during the forecast period.


Pancreatic-Stone-Protein-Testing-overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4566
  • Published Date: Jul 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of pancreatic stone protein testing is assessed at USD 4.21 Billion.

The pancreatic stone protein testing market size was valued at USD 4.11 Billion in 2023 and is set to reach USD 5.89 Billion by the end of 2036, expanding at around 2.8% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of diabetes globally along with rising demand for pancreatic stone protein testing as a biomarker are some of the major factors anticipated to drive the growth of the market.

North America is projected to hold largest industry share by 2036, attributed to high adoption of technological advancements, large patient pool, and well-developed healthcare infrastructure.

CUSABIO TECHNOLOGY LLC, LifeSpan BioSciences, Inc, Abbexa Limited, Boster Biological Technology CO LTD, Aviva Systems Biology Corporation, Glenmed Professional Healthcare Solutions., CREATIVE DIAGNOSTICS, Inc, Biomol GmbH, AMS Biotechnology (Europe) Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample